Clinical Trial Detail

NCT ID NCT01156584
Title A Study of a Retroviral Replicating Vector Administered to Subjects With Recurrent Malignant Glioma
Recruitment Completed
Gender both
Phase Phase I
Variant Requirements no
Sponsors Tocagen Inc.
Indications

malignant glioma

Therapies

Toca 511 + Toca FC

Age Groups: adult

No variant requirements are available.